Pages that link to "Template:DocumentData"

The following pages link to Template:DocumentData:

Displaying 50 items.

• Reference:AUT Question - BASG 11-Feb-2025 - (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.33 (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.64-002 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.36 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.150 (a) (3) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.150 (b) (5) (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Clinical Trial/Study Report (CSR) (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.13 (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 3.17.2 (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.10.1.6 (transclusion) (← links)
• Reference:ICH ICH E3 Guideline 1995 - (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - final report (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.16 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex D (transclusion) (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 23 - Final report (transclusion) (← links)
• Reference:N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008 - (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 37 Paragraph 4 (transclusion) (← links)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 77 Paragraph 4 – 5 (transclusion) (← links)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 77 Paragraph 6 – 7 (transclusion) (← links)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 73 Paragraph 5 (transclusion) (← links)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 77 Paragraph 4 – 5 (transclusion) (← links)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 77 Paragraph 6 – 7 (transclusion) (← links)
• Reference:EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 Annex III 2. ; 3. (transclusion) (← links)
• Reference:EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) VIII.B.4.3 (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 42b (transclusion) (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 62-003 (transclusion) (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 64 Absatz 3 (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63f (4) (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63g (4) (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 67 (6) - NIS (transclusion) (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.2.1 - Start (transclusion) (← links)
• Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.3.7 (transclusion) (← links)
• Reference:GBR HRA - Ending your project 28-Jan-2025 - (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.64 (c) - (d) (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.33 (a) (3) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.150 (a) (6) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.150 (b) (7)-002 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.40 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.44 (transclusion) (← links)
• Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.54 (transclusion) (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 36 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A A.17 (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 16 (transclusion) (← links)
• Reference:EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) VIII.B.5 (transclusion) (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 8 8.4 (transclusion) (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 10 (transclusion) (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 11 (transclusion) (← links)
• Reference:GBR Directive 93/42/EEC 11-Oct-2007 Annex X 2.2 (transclusion) (← links)
• Reference:DEU Deutsches Ärzteblatt 45849 - (transclusion) (← links)
• Reference:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 - (transclusion) (← links)